Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
CHMFL-FLT3-122 is an inhibitor of FMS-related tyrosine kinase 3 (FLT3; IC50 = 40 nM).1 It is selective for FLT3 over Bruton’s tyrosine kinase (BTK) and C-Kit (IC50s = 421 and 559 nM, respectively) and a panel of 468 additional kinases at 1 µM. CHMFL-FLT3-122 inhibits the growth of MV4-11, MOLM-13, and MOLM-14 acute myeloid leukemia (AML) cells containing FLT3 bearing an internal-tandem duplication (FLT3-ITD; GI50s = 22, 21, and 42 nM, respectively). In vivo, CHMFL-FLT3-122 (50 mg/kg) inhibits tumor growth in an MV4-11 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Discovery of (R)-